Columbia University Medical Center

BRCA1 mutation linked to highly aggressive uterine cancer

“Our study provides the strongest evidence to date that BRCA1 mutations are associated with a particularly aggressive form of uterine cancer,” Dr. Catherine Shu, a medical oncologist at Columbia University Medical Center, said in a press release.